Sentences with phrase «kidney disease using»

Today, high blood pressure is diagnosed in about 20 % of cats with chronic kidney disease using readily available equipment.

Pets with heart block, bradycardia (slow heart rate) and some types of heart failure Use with caution in diabetics or those with kidney disease Use with caution in animals with some types of lung disease (ex.

Use with caution in pets with liver or kidney disease Use with caution in older, debilitated animals, or those with certain types of glaucoma Use with caution in working dogs (military / police / seeing eye / hearing, etc.) as too much sedation may impede their ability to work and learn Pregnant and nursing animals Pets known to have had an allergic reaction to alprazolam or other benzodiazepine medications (ex.

Pets with heart block, a slow heart rate, sinus node dysfunction or congestive heart failure Use with caution in diabetics or those with liver or kidney disease Use with caution in animals with some types of lung disease (ex.

Use with care in pets with liver or kidney disease Use with extreme caution in pets with heart failure or a very slow heart beat Use with extreme caution in hyperthyroid pets Use with extreme caution in animals with some types of lung disease (ex.

Not exact matches

It does have a high potassium content so patients with kidney disease and on certain medications should check with their doctors before using.

BabyCentre recommends that you do not use essential oils if you have a history of miscarriage, have had vaginal bleeding during this pregnancy, have epilepsy, heart problems, diabetes, blood clotting, or thyroid, liver, or kidney disease.

A recently - developed mobile phone application could make monitoring conditions such as diabetes, kidney disease, and urinary tract infections much clearer and easier for both patients and doctors, and could eventually be used to slow or limit the spread of pandemics in the developing world.

Rheumatoid arthritis patients are likelier than the average person to develop chronic kidney disease, and more severe inflammation in the first year of rheumatoid arthritis, corticosteroid use, high blood pressure and obesity are among the risk factors, new Mayo Clinic research shows.

Health complications that often plague people living with HIV, and can prove fatal, might be reduced with the help of a drug already used to treat kidney disease — if it works as well in people as it does in monkeys.

To reduce their risk of developing kidney disease, patients should be attentive to their blood pressure and keep it under control, maintain a diet that isn't high in salt; avoid or reduce use of medications that are directly toxic to the kidneys; including nonsteroidal anti-inflammatory drugs; and get their rheumatoid arthritis and inflammation under as good of control as possible, he adds.

Using virtual tissue technology, researchers at Indiana University have identified a potential new drug target in the fight against polycystic kidney disease, an illness with no effective FDA - approved treatment that affects 200,000 people per year in the United States.

In this latest research, Mohan and his colleagues present new findings that detail the use of a synthetic, plant - derived compound — abbreviated CDDO — that was shown to effectively suppress the multiple steps of lupus development in murine models, including the onset of kidney disease.

More conventionally, EPO is used to treat anemia resulting from cancer, HIV / AIDS, and chronic kidney disease.

Co-researcher Dr Susan Francis, School of Physics, SPMIC added: «The team has a special interest in new types of functional MRI using novel targets like sodium as quantitative biomarkers of disease in the body, in particular in the kidney.

Kidney disease will be the main application of the research working in collaboration with the Centre for Kidney Research and Innovation (CKRI), but the team believes that Sodium MRI can also be used for more accurate diagnosis and monitoring of other diseases, and perhaps will give new insights into disease mechanisms as sodium management is important in the brain, lung, liver, and musculoskeletal system.

The use of stem cells in the treatment of feline chronic kidney disease, however, has been the exception.

Although some research has suggested that the use of the anticoagulant warfarin for atrial fibrillation among patients with chronic kidney disease would increase the risk of death or stroke, a study that included more than 24,000 patients found a lower l - year risk of the combined outcomes of death, heart attack or stroke without a higher risk of bleeding, according to a study in the March 5 issue of JAMA.

For this study, the researchers used data from a population of patients with both diabetes and chronic kidney disease (stage 3 and 4) enrolled in follow up studies conducted by Dr. Krolewski and his team at the Joslin Diabetes Center and followed for four to 15 years.

Using cell models and genetically engineered mice, the authors then could reproduce kidney disease changes upon expression of APOL1 gene variants, but the disease required the presence suPAR.

In another experiment, the researchers demonstrated that ExPath could be used to reliably diagnose kidney minimal - change disease (MCD) without the use of an electron microscope.

«We still need more studies to determine if there are other treatments that can be used to slow the progression of kidney disease specifically in individuals with sickle cell trait.»

«Although you can not change the genes you are born with, doctors can use this information to start screening for kidney disease earlier and to aggressively treat any other risk factors you may have such as diabetes or high blood pressure,» said Dr. Naik.

«In both studies, people who used a different class of medications to suppress stomach acid, known as H2 - blockers, did not have a higher risk of developing kidney disease,» said Dr. Lazarus.

«The kidney is a very solid organ, which makes it very difficult to bring enough number of cells upon transplantation,» explains Professor Kenji Osafune, whose lab at the Center for iPS Cell Research and Application (CiRA) at Kyoto University, Japan, is using iPSCs to investigate new treatments for kidney disease.

«Also, by using iPS cells from patients, development of new drugs and clarification of the causes of kidney disease are also expected.»

A drug currently used to treat autoimmune disease may also help prevent the kidney - damaging effects of diabetes, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

Investigators led by Suma Prakash, MD, FRCPC, MSc (Case Western Reserve University) wondered whether a model called the «behavioral stage of change» model, which was originally used to help people quit smoking, might help patients with chronic kidney disease take action and make decisions about their dialysis options.

«The high protein diet that has been used increasingly in recent years to control weight gain and obesity may have deleterious impacts on kidney health in the long term,» said Kalantar - Zadeh, director of the Harold Simmons Center of Kidney Disease Research and Epidemiology, and chief of the Division of Nephrology and Hypertension, UC Irvine School of Medkidney health in the long term,» said Kalantar - Zadeh, director of the Harold Simmons Center of Kidney Disease Research and Epidemiology, and chief of the Division of Nephrology and Hypertension, UC Irvine School of MedKidney Disease Research and Epidemiology, and chief of the Division of Nephrology and Hypertension, UC Irvine School of Medicine.

Using our approach we are starting to understand how kidney disease develops at the level of a single cell.»

In order to address this, Greka and her colleagues began their investigation with a rare genetic type of kidney disease, and, using a rat model, set out to understand the genes, proteins, and pathways involved in the organ's deterioration.

Using mice bred to lack some types of lymphoid cells, among other features, researchers were able to show that those mice still had high levels of suPAR and proteinuria, indicating that lymphoid cells were not the perpetrators of kidney disease.

The team also investigated the risk of infection while taking into account the duration of current or former statin use, 90 - day cumulative dose, and specific sub-groups of patients who were prescribed statins for different chronic conditions like previous myocardial infarction, peripheral arterial disease, chronic heart failure, chronic kidney disease, and diabetes.

«Results from our observational study in young adults with normal kidney function may not translate into a clinically meaningful difference and may be insufficient to inform decision - making concerning marijuana use; however, it is possible that the association between marijuana use and kidney function could be different in other populations such as older adults or patients with kidney disease, so additional research is needed,» said Dr. Ishida.

Evolution In recent years, athletes including cyclists have used drugs called HIF stabilizers (hypoxia inducible factor), an emerging class of kidney - disease drugs that stimulate the body's own production of EPO by activating genes to express EPO.

Research is needed to evaluate the impact of marijuana use in adults 60 and over, and among those with existing or at risk of developing kidney disease.»

«Our ultimate hope would be to use these findings to create a lipoxin - based drug for obese people to help protect them against associated illnesses, such as kidney and liver disease,» she said.

There was no statistically significant association between history of marijuana use and the likelihood of developing stage 2 or greater chronic kidney disease.

Progression of chronic kidney disease associated with progressive fibrosis and impaired tubular epithelial regeneration is still an unmet biomedical challenge, because once chronic lesions have manifested, no effective therapies are available as of yet for clinical use.

Dr. Diamantidis» research interests include the use of mobile technologies to promote patient engagement in chronic disease, person - centered chronic kidney disease care, patient safety, and health disparities in kidney disease.

Using postmortem kidneys donated from generous Medalists, the Joslin team looked at the levels of thousands of proteins expressed in kidney cells that help to filter blood, and compared the results for Medalists with and without kidney disease.

$ 1.8 M Supports Cancer Drug Discovery on Commonly Mutated Gene New Brunswick Patch — April 5, 2016 Behavioral Scientist Shares Insights about FDA's Proposed Rule on Banning Tanning Bed Use among Minors News-Medical.net - March 19, 2016 Intervention Program Reduces Caregiver Distress during Hospitalization of Pediatric Stem Cell Transplant Patients News-Medical.net - March 9, 2016 Exploring Genomic Pathways in the Development of Ovarian Cancer GMNews.com - March 2, 2016 Differences in Type of Small Protein may further Elucidate Lung Cancer Risk in African Americans ScienceDaily.com - March 2, 2016 Study Looks at Post-Treatment Resources for Prostate Cancer Patients Transitioning to Survivorship News-Medical.net - February 11, 2016 Drawing the Line on Tanning Bed Use by Teens ScienceDaily.com - December 21, 2015 What Rutgers Study Uncovered about E-Cigarette Use NJBiz.com - December 9, 2015 Identification of Barrier that Prevents Progression of Benign Kidney Tumors to Malignant Disease MedicalNewsToday.com - November, 24, 2015 What is the Color of the Lung Cancer Ribbon?

«This is a landmark paper for using the fly to study genetic kidney diseases,» Dr. Han said.

Stem cell therapy is used to treat incurable diseases like Cerebral Palsy, Brain Hemorrhage and Stroke, Spinal Cord Injury & Paraplegia, Autism, Parkinsonism, Motor Neuron Disease, Muscular Dystrophy, Liver Diseases, Huntington's Disease, Chronic Kidney Diseases, Optic Neuritis, Multiple Sclerosis, Cerebellar Ataxia and Friedrich Ataxia.

Earlier detection would enable the use of anticoagulation therapy to mitigate the risk of stroke and other complications such as dementia, chronic kidney disease and heart attack.

Edward Bullmore, UK Robert Dow, UK Garrett Fitzgerald, USA - Prostanoid biology and the role of peripheral molecular clocks in cardiovascular biology, metabolism and aging Alex Phipps, UK - Oncology, Clinical Pharmacology, Biologics and Immunotherapy Patrick du Souich, Canada - Cytochrome P450, membrane carriers, disease, inflammation, rational use of drugs, clinical pharmacology David J. Webb, UK - hypertension, chronic kidney disease, endothelial function and dysfunction, arterial stiffness, health technology assessment, medicines regulation Don Birkett, Australia - Clinical pharmacology / pharmacokinetics and drug utilisation

Use of the prescription heartburn drugs already has been linked to short - term kidney problems such as acute kidney injury and an inflammatory kidney disease called acute interstitial nephritis, Grams said.

They found twice - daily use was associated with a 46 percent increased risk of chronic kidney disease, versus a 15 percent increased risk in those taking one daily dose.

Examples of these medications used to treat Crohn's disease include: adalimumab (Humira), infliximab (Remicade), certolizumab (Cimzia) and ustekinumab (Stelara), according to the U.S. National Institute of Diabetes and Digestive and Kidney Diseases.

People who use proton pump inhibitors (PPIs) have a 20 percent to 50 percent higher risk of chronic kidney disease compared with nonusers, said lead author Dr. Morgan Grams, an assistant professor of epidemiology at Johns Hopkins University in Baltimore.